Bio Rad Laboratories Inc reports results for the quarter ended December 31 - Earnings Summary

Bio-Rad Laboratories

13/02/2025 22:02

* Bio Rad Laboratories Inc  BIO.N  reported quarterly
adjusted
earnings of $2.90​​ per share for the quarter ended December 31,
lower than the same quarter last year, when the company reported
EPS of $3.10.  The mean expectation of seven analysts for the
quarter was for earnings of $2.87 per share. Wall Street
expected results to range from $2.73  to $2.98 per share.
    * Revenue fell 2% to $667.50 million from a year ago;
analysts
expected $679.30 million. 
    * Bio Rad Laboratories Inc's reported EPS for the quarter
was a
loss of $25.57​.
    * The company reported a quarterly loss of $715.8 million.
    * Bio Rad Laboratories Inc shares had fallen by 4.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Bio Rad
Laboratories Inc is $395.00 
This summary was machine generated from LSEG data February 13 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      2.87           2.90           Beat
 Sep. 30 2024      1.16           2.01           Beat
 Jun. 30 2024      2.01           3.11           Beat
 Mar. 31 2024      2.15           2.29           Beat